Search Results - "David Schweer"

Human macrophage-engineered vesicles for utilization in ovarian cancer treatment by Schweer, David, Anand, Namrata, Anderson, Abigail, McCorkle, J Robert, Neupane, Khaga, Nail, Alexandra N, Harvey, Brock, Hill, Kristen S, Ueland, Frederick, Richards, Christopher, Kolesar, Jill

“…Ovarian cancer is a deadly female malignancy with a high rate of recurrent and chemotherapy-resistant disease. Tumor-associated macrophages (TAMs) are a…”
Get full text

Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer by Schweer, David, McCorkle, J Robert, Rohr, Jurgen, Tsodikov, Oleg V, Ueland, Frederick, Kolesar, Jill

“…Ovarian cancer is a highly deadly malignancy in which recurrence is considered incurable. Resistance to platinum-based chemotherapy bodes a particularly…”
Get full text

Targeting receptor tyrosine kinases in ovarian cancer: Genomic dysregulation, clinical evaluation of inhibitors, and potential for combinatorial therapies by Wei, Ying, Erfani, Sonia, Schweer, David, de Gouvea, Rafael, Qadir, Javeria, Shi, Junfeng, Cheng, Kai, Wu, Dabao, Craven, Rolf, Wu, Yadi, Olivier, Thibault, Baldwin, Lauren A., Zhou, Binhua, Zhou, Ying, Zhao, Weidong, Yang, Burton B., Ueland, Frederick R., Yang, Xiuwei H.

“…Epithelial ovarian cancer (EOC) remains one of the leading causes of cancer-related deaths among women worldwide. Receptor tyrosine kinases (RTKs) have long…”
Get full text

Robotic-assisted interval cytoreductive surgery in ovarian cancer: a feasibility study by Carbajal-Mamani, Semiramis L, Schweer, David, Markham, Merry J, Esnakula, Ashwini K, Grajo, Joseph R, Castagno, Jacqueline C, Cardenas-Goicoechea, Joel

“…The primary objective was to assess the feasibility of robotic-assisted interval cytoreductive surgery for achieving complete cytoreduction for patients with…”
Get full text

Evaluating Blood Loss and the Effect of Antiplatelet Treatment in Foot and Ankle Amputations by Schweer, David, MD, Carmouche, Jonathon J., MD, Jupiter, Daniel, PhD, Ball, Timothy, MD, PhD, Clements, J. Randolph, DPM

“…Abstract The interrelationship between diabetes mellitus and cardiovascular disease is well-documented, and, secondary to the latter, is the use of…”
Get full text

Robotic-assisted interval cytoreductive surgery in ovarian cancer: a feasibility study by Semiramis L. Carbajal-mamani, David Schweer, Merry J. Markham, Ashwini K. Esnakula, Joseph R. Grajo, Jacqueline C. Castagno, Joel Cardenas-goicoechea

“…Objective The primary objective was to assess the feasibility of robotic-assisted interval cytoreductive surgery for achieving complete cytoreduction for…”
Get full text

Tumor-Associated Macrophages and Ovarian Cancer: Implications for Therapy by Schweer, David, McAtee, Annabel, Neupane, Khaga, Richards, Christopher, Ueland, Frederick, Kolesar, Jill

“…The tumor microenvironment (TME) has been implicated to play an important role in the progression of ovarian cancer. One of the most important components of…”
Get full text

Cisplatin encapsulated human macrophage-engineered vesicles for utilization in ovarian cancer treatment by Schweer, David, Anand, Namrata, Cao, Connie, McCorkle, J. Robert, Ueland, Frederick, Richards, Christopher, Kolesar, Jill

Get full text

Survival analysis of a prospective intraoperative algorithm to guide surgical staging in early-stage endometrial cancer by Schweer, David, Harbin, Laura, Fredericks, Tricia, Branch, Lauren Baldwin, Dietrich, Charles, Yan, Donglin, Ueland, Frederick

Get full text

Decreased Narcotic Use After the Implementation of ERAS Guidelines in Gynecologic Oncology at an Academic Center [24H] by Plasencia, Elizabeth, Mamani, Semiramis Carbajal, Schweer, David, Goicoechea, Joel Cardenas

Get full text

Human macrophage-engineered vesicles for utilization in ovarian cancer treatment (179) by Schweer, David, Anderson, Abigail, Anand, Namrata, McCorkle, J. Robert, Neupane, Khaga, Hill, Kristen, Ueland, Frederick, Richards, Christopher, Kolesar, Jill

Get full text

Development of a Risk Assessment Tool for Surgical Site Infections (SSI) in an OBGYN Patient Population [18I] by Schweer, David, Byun, Sharon Y, Davis, John D, Weber LeBrun, Emily Elise

“…INTRODUCTION:Surgical site infections (SSI), are defined as superficial, deep, or organ space infections that occur within 30 days of surgery. SSIs are known…”
Get full text

Mithplatins: Mithramycin SA‐Pt(II) Complex Conjugates for the Treatment of Platinum‐Resistant Ovarian Cancers by Bhosale, Suhas S., Mandal, Abhisek, Hou, Caixia, McCorkle, J. Robert, Schweer, David, Hill, Kristen S., Subramanian, Vivekanandan, Kolesar, Jill M., Tsodikov, Oleg V., Rohr, Jürgen

“…DNA coordinating platinum (Pt) containing compounds cisplatin and carboplatin have been used for the treatment of ovarian cancer therapy for four decades…”
Get full text

Abstract B020: M1 macrophage engineered vesicles as ovarian cancer treatment in a mouse xenograft model by Cao, Connie D., McCorkle, Joseph R., Anand, Namrata, Yan, Donglin, Schweer, David, Li, Lan, Boggs, Tanner, Allison, Derek B., Dietrich, Charles S., Ueland, Frederick R., Richards, Christopher I., Kolesar, Jill M.

“…Ovarian cancer is the deadliest gynecologic cancer in the United States, and new treatment strategies are needed. We have developed M1 (anticancer) derived…”
Get full text

Incidence of venous thromboembolism after robotic-assisted hysterectomy in obese patients with endometrial cancer: do we need extended prophylaxis? by Carbajal-Mamani, Semiramis L., Dideban, Bahram, Schweer, David, Balavage, Kristi T., Chuang, Linus, Wang, Yu, Wang, Shu, Lee, Ji-Hyun, Amaro, Bernie, Cardenas-Goicoechea, Joel

“…Robotic surgery for gynecologic malignancy is associated with a lower rate of venous thromboembolism (VTE) than laparotomy. Obese patients represent a…”
Get full text